Studies related to Symptoms of Schizophrenia and Glycine

High-dose Glycine Added To Olanzapine And Risperidone For The Treatment Of Schizophrenia

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 17
Sex Both Genders
Age Range 30-44, 45-64
Notes for this study:
800mg/kg of glycine daily for 6 weeks in persons with schizophrenia on stable antipsychotic therapy was able to further reduce symptoms with particular efficacy against negative symptoms (23+/-8% reduction).

Full details on all 1 studies are available to Examine Plus members.

Already a member? Login now to access.